Rob Perez

Operating Partner

REGION United States


Rob Perez is an Operating Partner and part of General Atlantic’s Operations Group, providing strategic support and advice to the firm’s investment team and portfolio companies in the Life Sciences sector. Before joining General Atlantic in 2019, he was Managing Director of Vineyard Sound Advisors, LLC, an advisory practice focused on growth companies in the biopharma industry. Prior to that, Rob was President and CEO of Cubist Pharmaceuticals, Inc. before its sale to Merck in 2015. Before joining Cubist in 2003, he served as Vice President of Biogen, Inc.’s CNS Business Unit.

Current Board Affiliations

PathAI, Board Member
Immunocore, Board Member
Akili Interactive, Executive Chairman
Vir Biotechnology, Board Member

Historical Board Affiliations

AMAG Pharmaceuticals (NASDAQ: AMAG), Board Member
Cidara Therapeutics (NASDAQ: CDTX), Board Member
Cubist Pharmaceuticals, Inc., Board Member
Flex Pharma (NASDAQ: FLKS), Board Member
ImmusanT, Board Member
Spark Therapeutics (NASDAQ: ONCE), Board Member
Unum Therapeutics, Inc. (NASDAQ: UMRX), Board Member
Zafgen Inc. (NASDAQ: ZFGN), Board Member


California State University, Los Angeles, B.S., Business
Anderson Graduate School of Management at the University of California, Los Angeles, M.B.A.

Community Involvement

Dana-Farber Cancer Institute, Member, Board of Trustees
Life Science Cares, Inc., Founder and Chairman